Market Review: Large-Cap Breather Sparks Small-Cap Explosion

The trading session on Friday, May 22, 2026, showcased a classic and powerful textbook rotation. Following yesterday’s historic +8% large-cap short squeeze, the benchmark KOSPI entered a healthy consolidation phase, climbing 38.30 points (+0.49%) to close at 7,853.62.

In stark contrast, the tech-and-bio-heavy KOSDAQ staged an absolute rout of short sellers, skyrocketing +4.84% to finish at 1,159.55.

With Samsung’s labor gridlock effectively deactivated and crude prices stabilizing on systemic Middle East peace drafts, market participants aggressively pivoted from heavy defensive large-caps into severely beaten-down small- and mid-cap growth equities.

1. The 150 Trillion KRW Liquidity Wave: National Growth Fund Dominance

The core engine behind the KOSDAQ’s massive outperformance was a series of profound institutional liquidity announcements.

The National Growth Fund Sell-out

The Ministry of Economy and Finance confirmed that the retail allocation tranche (600 billion KRW) of the newly launched National Growth Fund was completely filled and closed almost instantly. This vehicle—designed to deploy 150 trillion KRW over the next five years via public-private matching structures—is legally bound to concentrate on high-growth sectors: AI, advanced semiconductors, biotechnology, robotics, and aerospace. The immediate influx of frontline capital completely reshaped short-term trading sentiment.

Pension Fund Buffers

Simultaneously, the National Pension Service (NPS) advanced plans to widen its domestic equity investment ceiling, pushing its maximum asset allotment top line from 19.9% up to 24.9%. This strategic widening effectively eliminates the chronic market headwind of institutional "dumping blocks" whenever the KOSPI moves higher, securing a structural floor for domestic assets.

2. Geopolitical Progress Met With Intraday Compliance Friction

Geopolitical updates remained generally constructive, though late-afternoon noise triggered a temporary wave of derivative volatility.

• The Peace Blueprints: International mediators confirmed they are actively polishing the first official draft of a comprehensive US-Iran peace framework. The core tenets include a total cessation of military actions, mutual non-aggression pacts regarding critical energy infrastructure, guaranteed freedom of navigation through international straits, and a phased, step-by-step rolling back of Western economic sanctions.
• The Uranium Disinformation: Conflicting early reports that Ayatollah Khamenei had forbidden the transport of enriched uranium out of the country were largely debunked as internal political posturing by hardliners attempting to stall the talks.
• The Binance Headwind: Intraday momentum stuttered briefly following reports that the US Department of Justice is actively investigating digital asset routes, suspecting that Iran-linked entities utilized decentralized infrastructure to bypass legacy monitoring systems. This headline immediately correlated with a temporary shakeout in US stock futures before broader market buyers stepped back in.

3. High-Conviction Growth Clusters: ASCO Bio and Quantum Funding

With heavy semiconductors stepping into a short-term consolidation window post-Nvidia, retail and venture capital rushed into two hyper-growth tech clusters:

The ASCO Bio-Tech Surge

Anticipation surrounding the upcoming American Society of Clinical Oncology (ASCO 2026) annual meeting reached a fever pitch. Coinciding with the National Growth Fund launch, several domestic oncology firms disclosed remarkable abstract data:

• Targeted Monoclonal Advancements: Leading pipelines posted impressive Objective Response Rates (ORR) up to 40% in advanced renal cell carcinoma cohorts.
• AI Diagnostic Integration: Digital pathology firms confirmed they will present five distinct clinical validation studies focusing on AI-driven IHC biomarker screening models.

Transatlantic Quantum Subsidy Boost

The quantum computing and secure encryption sectors experienced an explosive wave of momentum following confirmation that the US Federal Government is deploying $2 billion (approx. 3 trillion KRW) in direct capital grants and equity stakes across nine foundational quantum hardware operators. This policy pivot drove multiple low-float domestic secure-ledger, hardware sensor, and optical cryptography plays straight to their +30% daily limits.

┌────────────────────────────────────────────────────────┐
│        May 22 Growth Rotation Catalyst Board           │
├────────────────────────────────────────────────────────┤
│  • National Growth Fund: 150 Trillion KRW Policy Allocation │
│  • NPS Domestic Equity Cap: Expanded to 24.9% (+5.0%)  │
│  • US Quantum Infrastructure Grant: $2 Billion Injected │
└────────────────────────────────────────────────────────┘

K-Stock Radar & ETF Watch: The Rotation Seven

As retail investors unloaded over 1 trillion KRW across both exchanges to lock in near-term profits, domestic institutional desks and foreign trend-followers deployed aggressive net accumulation into small-cap growth clusters.

1. Hanall Biopharma (009420)
Locked an explosive +29.85% limit up, extending its run after its core autoimmune asset, IMVT-1402, delivered exceptionally clean, ahead-of-schedule clinical data for refractory rheumatoid arthritis. It stands as the premier large-cap beneficiary of the bio-tech revival.

2. OCI Holdings (010060)
Surged +12.3% on intense volume. The company is benefiting from a dual catalyst path: the integration of smart solar grids into AI power infrastructure and expanding advanced chemical supply chain partnerships with Western aerospace leaders like SpaceX.

3. Ligachem Biosciences (141080)
Advanced a spectacular +13.7% as international fund managers front-run the upcoming ASCO presentations. Its top-tier Antibody-Drug Conjugate (ADC) technology platform positions it as a primary target for upcoming global out-licensing deals.

4. KBI Metal (024840)
Maintained its incredible momentum, capturing another +30.00% back-to-back limit up. The legislative tailwinds of the newly passed Power Grid Trio, combined with its high-margin transition into automated transformer component manufacturing, have made it the definitive face of the infrastructure boom.

5. MakinaRocks (478140)
Rose yet another +30.00% limit up, completing a flawless three-day post-IPO surge. As the definitive industrial AI automation play on the exchange, its software solutions sit directly at the center of the National Growth Fund’s primary target mandates.

6. TIGER KOSDAQ 150 (233310)
The absolute vehicle of choice for today’s trade. With the KOSDAQ clearing historically oversold technical extremes and state-directed growth funds focusing heavily on mid-cap tech and healthcare, this index tracking fund offers immediate diversification into the rotation.

7. TIGER MedTech (102270)
Provides highly concentrated exposure across Korea’s premier digital healthcare, surgical robotics, and AI-driven diagnostic screening developers. It bypasses single-asset biotech trial risks while fully capturing the ASCO-driven policy tailwinds.

Strategic Summary: Today’s price action demonstrates excellent structural health. A healthy market should not rely solely on two mega-cap semiconductor firms to move higher. The tactical pause in large-cap hardware, combined with the explosive capital inflows into biotech, quantum infrastructure, and solar grids, shows that the broader market is finding its footing. With massive macro safety valves like the 150 trillion KRW National Growth Fund shifting into active status, the floor under the Korean growth market has substantially firmed up. Maintain a balanced approach, holding core semiconductor positions while adding to high-conviction KOSDAQ growth leaders.